Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109016386 | 10901638 | 6 | F | 20160909 | 20150310 | 20160914 | EXP | US-PFIZER INC-2015082252 | PFIZER | 82.00 | YR | M | Y | 95.00000 | KG | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109016386 | 10901638 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | U | 20235 | 300 | MG | CAPSULE, HARD | TID | |||||
| 109016386 | 10901638 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | U | 20235 | CAPSULE, HARD | ||||||||||
| 109016386 | 10901638 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | U | 20235 | CAPSULE, HARD | ||||||||||
| 109016386 | 10901638 | 4 | SS | NEURONTIN | GABAPENTIN | 1 | U | 20235 | CAPSULE, HARD | ||||||||||
| 109016386 | 10901638 | 5 | C | DEXALIN | 2 | UNK | 0 | ||||||||||||
| 109016386 | 10901638 | 6 | C | OCUVITE PRESERVISION | 2 | UNK | 0 | ||||||||||||
| 109016386 | 10901638 | 7 | C | HYTRIN | TERAZOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 109016386 | 10901638 | 8 | C | FISH OIL | FISH OIL | 1 | UNK | 0 | |||||||||||
| 109016386 | 10901638 | 9 | C | COENZYME Q10 | UBIDECARENONE | 1 | 200 MG, UNK | 0 | 200 | MG | |||||||||
| 109016386 | 10901638 | 10 | C | TUMERIC | TURMERIC | 1 | UNK | 0 | |||||||||||
| 109016386 | 10901638 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 109016386 | 10901638 | 12 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109016386 | 10901638 | 1 | Pain in extremity |
| 109016386 | 10901638 | 2 | Back pain |
| 109016386 | 10901638 | 3 | Neuralgia |
| 109016386 | 10901638 | 4 | Spinal pain |
| 109016386 | 10901638 | 5 | Gastric disorder |
| 109016386 | 10901638 | 7 | Prostatic disorder |
| 109016386 | 10901638 | 8 | Blood cholesterol abnormal |
| 109016386 | 10901638 | 9 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109016386 | 10901638 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109016386 | 10901638 | Back disorder | |
| 109016386 | 10901638 | Drug ineffective for unapproved indication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |